XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization , Description of Business and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Third-party Payers as a Percentage of Total
The Company’s third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:
 
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Medicare31 %31 %31 %31 %
UnitedHealthcare10 %%10 %10 %
 41 %40 %41 %41 %

The Company’s third-party payers and other customers in excess of 10% of accounts receivable and their related accounts receivable balance as a percentage of total accounts receivable were as follows at the following dates:
 
 September 30, 2022December 31, 2021
Medicare14 %12 %
UnitedHealthcare10 %%
Schedule of Revenue Revenue included in biopharmaceutical and other revenue for the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands of dollars):
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
Biopharmaceutical revenue$6,368 $5,241 $20,820 $7,431 
Contract manufacturing and testing1,333 1,273 5,743 1,273 
Total$7,701 $6,514 $26,563 $8,704